When the tumor volumes reached approximately 200 mm3, mice were grouped and treated with GPC3-28Z CAR-T cells or GPC3-Syn-IL12-NK92 cells or their combination in a 1:1 ratio. This evidence concerns the gene GPC3 and neoplasm.